Symbiosis Pharmaceutical Services

Symbiosis Pharmaceutical Services Ltd (Symbiosis) is a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) established in 2011 in Stirling, UK, to provide niche sterile manufacturing services to GMP standards and produce injectable products for its clients to use in thier clinical trials or to supply specialist commercial markets. In 2011, Symbiosis set out to be a UK-located service provider to an international biotechnology and pharmaceutical market and to create wealth and jobs in the life sciences sector in Scotland. The Scottish economic development agency, Scottish Enterprise, was instrumental in supporting the start-up of the company and provided investment capital through its investment arm, the Scottish Investment Bank (SIB). The company has a manufacturing facility which can manufacture biologic, vaccine, or small-molecule sterile bio/pharmaceutical products for biotechnology and pharmaceutical clients globally who are developing medicines to treat cancers and neurodegereative diseases, for example. The company also has an office in Cambridge, Massachussetts, which services an increasing proportion of US clients. Manufacturing is undertaken in an FDA-approved and MHRA-licensed facility which is regulated to facilitate the handling of biological products including the latest drug development technologies in the field of Advanced Therapeutic Medicinal Products (ATMPs) such as viral vector-based therapeutic and vaccine products.